Thea C. Norman
Affiliations: | Sage Bionetworks |
Area:
Computational Biology, Open Science, Mobile Health ApplicationsGoogle:
"Thea Norman"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Stuart L. Schreiber | grad student | 1988-1989 | Harvard |
| Clayton H. Heathcock | grad student | 1990-1994 | UC Berkeley |
| Peter G. Schultz | post-doc | 1994-1996 | UC Berkeley |
| Andrew W. Murray | post-doc | 1996-1999 | UCSF |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Menden MP, Wang D, Mason MJ, et al. (2019) Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen. Nature Communications. 10: 2674 |
| Cho H, Daniel T, Buechler YJ, et al. (2011) Optimized clinical performance of growth hormone with an expanded genetic code. Proceedings of the National Academy of Sciences of the United States of America. 108: 9060-5 |
| HEATHCOCK CH, BROWN RCD, NORMAN TC. (2010) ChemInform Abstract: Synthesis of Petrosins C (I) and D (II). Cheminform. 29: no-no |
| KIM J, WILSON TE, NORMAN TC, et al. (2010) ChemInform Abstract: Synthesis of a Cyclic Urea as a Nonnatural Biopolymer Scaffold. Cheminform. 27: no-no |
| Askenazi M, Driggers EM, Holtzman DA, et al. (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nature Biotechnology. 21: 150-6 |
| Norman TC, Smith DL, Sorger PK, et al. (1999) Genetic selection of peptide inhibitors of biological pathways. Science (New York, N.Y.). 285: 591-5 |
| Chang YT, Gray NS, Rosania GR, et al. (1999) Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chemistry & Biology. 6: 361-75 |
| Gray NS, Wodicka L, Thunnissen AM, et al. (1998) Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (New York, N.Y.). 281: 533-8 |
| Brooks EE, Gray NS, Joly A, et al. (1997) CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. The Journal of Biological Chemistry. 272: 29207-11 |
| Norman TC. (1997) Puzzling it out Current Biology. 7: R521 |